TCT 146: Treatment of calcified de novo coronary artery lesions with drug-coated balloon after intravascular lithotripsy

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Biotronik; Chiesi; Cordis Corporation, a Johnson & Johnson company; Nipro Medical; Shockwave Medical; Getinge; Boston Scientific Corporation</li><li>Grant Support/Research Contract - B Braun</li></ul>